115 related articles for article (PubMed ID: 336499)
1. [Cytopherometry in neurologic diseases (author's transl)].
Meyer-Rienecker HJ; Jenssen HL; Köhler H; Werner H
Fortschr Neurol Psychiatr Grenzgeb; 1977 Nov; 45(11):615-29. PubMed ID: 336499
[TBL] [Abstract][Full Text] [Related]
2. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
[TBL] [Abstract][Full Text] [Related]
3. [Cellular immunity in neurological diseases. Results with myelinbasic protein (author's transl)].
Meyer-Rienecker H; Jenssen HL; Köhler H; Lehmitz R; Schmieter K
Nervenarzt; 1979 Jan; 50(1):10-5. PubMed ID: 85265
[No Abstract] [Full Text] [Related]
4. [Demonstration of a factor in cerebrospinal fluid with inhibitory activity for electrophoretic cell mobility in multiple sclerosis (author's transl)].
Jenssen HL; Meyer-Rienecker HJ; Werner H
J Neurol; 1976 Nov; 214(1):45-59. PubMed ID: 62827
[TBL] [Abstract][Full Text] [Related]
5. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
[TBL] [Abstract][Full Text] [Related]
6. [Heterogenous immune reactivity in brain tumors: results of cellular immunity in relation to brain tissue antigens].
Meyer-Rienecker HJ; Jenssen HL; Mix E
Fortschr Neurol Psychiatr; 1985 Oct; 53(10):363-9. PubMed ID: 2415433
[TBL] [Abstract][Full Text] [Related]
7. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
8. [Immunogenetic aspects of neuroimmunologic diseases].
Meyer-Rienecker HJ; Hitzschke B; Wegener S; Jenssen HL
Z Arztl Fortbild (Jena); 1983; 77(1):7-12. PubMed ID: 6845759
[No Abstract] [Full Text] [Related]
9. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Field EJ; Caspary EA; Smith KS
Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
[TBL] [Abstract][Full Text] [Related]
10. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic problem in multiple sclerosis (M.S.): two specific laboratory tests.
Field EJ
Boll Ist Sieroter Milan; 1978 Jan; 56(6):552-6. PubMed ID: 75734
[TBL] [Abstract][Full Text] [Related]
12. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas.
Lee Y; Bigner DD
Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
[TBL] [Abstract][Full Text] [Related]
14. [Developmental trends in neuroimmunology. 1: Principles, immuno-components, immunogenetics, contributions of virology].
Meyer-Rienecker HJ
Nervenarzt; 1984 Dec; 55(12):617-24. PubMed ID: 6441125
[No Abstract] [Full Text] [Related]
15. Neuroimmunology I: Immunoregulation in neurological disease.
Weiner HL; Hauser SL
Ann Neurol; 1982 May; 11(5):437-49. PubMed ID: 6179458
[TBL] [Abstract][Full Text] [Related]
16. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the macrophage electrophoretic mobility test and the leukocyte migration inhibition test in the detection of histocompatibility antigens on tumor cells.
Bubeník J; Cochran AJ; Todd G; Malkovský M; Jandlová T; Suhajová E; Boubelík M
Neoplasma; 1981; 28(2):185-93. PubMed ID: 7019742
[TBL] [Abstract][Full Text] [Related]
18. Applications of the macrophage electrophoretic mobility test (M.E.M.).
Shenton BR
Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
Kondo H; Rabin BS; Rodnan GP
J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
[TBL] [Abstract][Full Text] [Related]
20. [Recording of cell-mediated immunity in patients with gliomatous brain tumors].
Lambrecht R; Willenberg E; Plate M
Z Exp Chir Transplant Kunstliche Organe; 1986; 19(3):167-71. PubMed ID: 3751205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
